Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Lattice Biologics Ltd (LBL) NPV

Sell:0.03 CAD Buy:0.035 CAD Change: No change
Market closed |  Prices as at close on 30 October 2020 | Switch to live prices |
Sell:0.03 CAD
Buy:0.035 CAD
Change: No change
Market closed |  Prices as at close on 30 October 2020 | Switch to live prices |
Sell:0.03 CAD
Buy:0.035 CAD
Change: No change
Market closed |  Prices as at close on 30 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Lattice Biologics Ltd. (Lattice) is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company is a precision medicine company in the field of cellular therapies and tissue engineering, with a focus on bone, skin and cartilage regeneration. It produces and distributes multiple allograft tissue products used by surgeons as bone, skin and cartilage tissue void fillers. Its products include Acellular Demineralized Bone Scaffold, Demineralized Bone Matrix putty (DBM Putty), Acellular dermal matrix (ADM) dermal scaffold and Other Products. Its products are used in a range of applications, including enhancing fusion in spine surgery; enhancing breast reconstruction post mastectomy; sports medicine indications, including anterior cruciate ligament repair and promotion of bone growth in foot; promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries.

Contact details

Address:
16701 N 90th St Ste 101
SCOTTSDALE
85260-1012
United States
Telephone:
+1 (604) 2356701
Website:
www.latticebiologics.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LBL
ISIN:
CA5184101056
Market cap:
3.13 million CAD
Shares in issue:
104.29 million
Sector:
Biotechnology
Exchange:
Canadian Venture Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Donald McInnes
    Chairman of the Board, President, Chief Executive Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.